Procedural Sedation Using Propofol Versus Midazolam/Ketamine in the Adult Emergency Department
Primary Purpose
Procedural Sedation
Status
Completed
Phase
Phase 4
Locations
Israel
Study Type
Interventional
Intervention
Ketamine/Midazolam
Propofol
Sponsored by
About this trial
This is an interventional treatment trial for Procedural Sedation focused on measuring Procedural sedation and analgesia, Emergency Department, propofol versus ketamine and midazolam, painful orthopedic manipulations
Eligibility Criteria
Inclusion Criteria:
- Patients with orthopedic injuries requiring painful manipulation (i.e. reduction of fracture or dislocation, drainage of abscess, suture of extensive laceration)
- Age between18-65 years
- American Society of Anesthesiologists (ASA) score of 1 or 2
- Systolic blood pressure higher than 90 mmHg and lower than 160 mmHg before initiating sedation
- Willingness and ability to provide an informed consent
- No known hypersensitivity to either medication
- No evidence of intoxication
- No recent heavy meal.
Exclusion Criteria:
- Pregnant women and patients who do not meet the above criteria will be excluded.
Sites / Locations
- Tel Aviv Sourasky Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
midazolam/ketamine
propofol
Arm Description
Patients with orthopedic injuries requiring painful manipulation
Patients with orthopedic injuries requiring painful manipulation
Outcomes
Primary Outcome Measures
The effectiveness and safety profile of procedural sedation using propofol versus midazolam/ketamine.
Secondary Outcome Measures
The amnestic properties of procedural sedation with propofol versus midazolam/ketamine.
Full Information
NCT ID
NCT00784498
First Posted
November 2, 2008
Last Updated
July 31, 2010
Sponsor
Tel-Aviv Sourasky Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00784498
Brief Title
Procedural Sedation Using Propofol Versus Midazolam/Ketamine in the Adult Emergency Department
Official Title
Procedural Sedation for Painful Orthopedic Manipulations With Propofol vs. Midazolam/Ketamine in the Adult Emergency Department
Study Type
Interventional
2. Study Status
Record Verification Date
November 2008
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Tel-Aviv Sourasky Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The use of procedural sedation and analgesia (PSA) to accomplish painful procedures in the emergency department (ED) has become a standard of practice over the last decade. Substantial variance exists regarding usage of medication for PSA, and many anesthetic agents have been proposed for this use.
To our knowledge no head to head study compared the clinical effectiveness, safety profile and amnestic properties of midazolam/ketamine vs. propofol regimens for PSA in the adult ED setting.
This prospective randomized trail can will help to evaluate the effectiveness and safety profile of Midazolam/katamine regimen for ED PSA in adults and will contribute to the discussion regarding propofol roll in the ED.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Procedural Sedation
Keywords
Procedural sedation and analgesia, Emergency Department, propofol versus ketamine and midazolam, painful orthopedic manipulations
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
midazolam/ketamine
Arm Type
Active Comparator
Arm Description
Patients with orthopedic injuries requiring painful manipulation
Arm Title
propofol
Arm Type
Active Comparator
Arm Description
Patients with orthopedic injuries requiring painful manipulation
Intervention Type
Drug
Intervention Name(s)
Ketamine/Midazolam
Intervention Description
Intravenous bolus of midazolam 0.1mg/kg in titrated dose of 1 mg/min until spontaneous eye closure or up to 5mg (whichever comes first) followed by ketamine 0.5-1mg/kg (up to 100mg) in titrated dose of 10mg/30 seconds, to achieve the desired level of sedation
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
Intravenous bolus of propofol 0.5-1mg/kg in titrated dose of 10mg/30seconds (up to 100mg) to achieve the desired level of sedation
Primary Outcome Measure Information:
Title
The effectiveness and safety profile of procedural sedation using propofol versus midazolam/ketamine.
Time Frame
outcome measures will be monitored continuously and will be documented every few minutes from initiating sedation until the patient returns to his/her basic mental status
Secondary Outcome Measure Information:
Title
The amnestic properties of procedural sedation with propofol versus midazolam/ketamine.
Time Frame
Recall issues will be assessed after the patient returns to his/her basic mental status and within 72 hours from the procedure (either on a follow up visit or by a phone call)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with orthopedic injuries requiring painful manipulation (i.e. reduction of fracture or dislocation, drainage of abscess, suture of extensive laceration)
Age between18-65 years
American Society of Anesthesiologists (ASA) score of 1 or 2
Systolic blood pressure higher than 90 mmHg and lower than 160 mmHg before initiating sedation
Willingness and ability to provide an informed consent
No known hypersensitivity to either medication
No evidence of intoxication
No recent heavy meal.
Exclusion Criteria:
Pregnant women and patients who do not meet the above criteria will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pinchas Halpern, MD
Organizational Affiliation
Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tel Aviv Sourasky Medical Center
City
Tel Aviv
Country
Israel
12. IPD Sharing Statement
Learn more about this trial
Procedural Sedation Using Propofol Versus Midazolam/Ketamine in the Adult Emergency Department
We'll reach out to this number within 24 hrs